BATS | ETF
The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the index as a whole.
The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology.
The fund is non-diversified.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
VERV | Verve Therapeutics Inc | Healthcare | Biotechnology | 5.08% |
DNA | Ginkgo Bioworks Holdings | Healthcare | Biotechnology | 3.61% |
NTLA | Intellia Therapeutics Inc | Healthcare | Biotechnology | 3.17% |
CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 3.00% |
SANA | Sana Biotechnology Inc | Healthcare | Biotechnology | 2.91% |
NSIS-B | Novonesis (Novozymes) A/S | Basic Materials | Specialty Chemicals | 2.54% |
NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.24% |
LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 2.23% |
AGIO | Agios Pharm | Healthcare | Biotechnology | 2.17% |
TXG | 10X Genomics Inc | Healthcare | Health Information Services | 2.13% |
BEAM | Beam Therapeutics Inc | Healthcare | Biotechnology | 1.97% |
GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 1.95% |
EDIT | Editas Medicine Inc | Healthcare | Biotechnology | 1.94% |
RGNX | Regenxbio Inc | Healthcare | Biotechnology | 1.89% |
BNTX | BioNTech SE | Healthcare | Biotechnology | 1.84% |
MRNA | Moderna Inc | Healthcare | Biotechnology | 1.72% |
UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 1.72% |
TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 1.72% |
AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 1.62% |
NOVN | Novartis AG | Healthcare | Drug Manufacturers - General | 1.62% |